COL6A3 and glioblastoma: We applied 101 machine learning algorithms to evaluate the prognostic and immunological value of COL6A3+ tumor-associated fibroblasts (TAFs) and GPNMB+ monocyte-derived macrophages (MDMs) in multiple GBM cohorts and immunotherapy cohorts.